WMK-2
WMK-2 is a 1,2,4,5-tetraoxane derivative and ferroptosis inducer with broad-spectrum anticancer activity. WMK-2 generates hydroxyl radicals and lipid ROS to induce ferroptosis in cancer cells and cancer stem cells. WMK-2 can be used for the research of cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2814563-63-6
- Formule: C38H49BrNO6P
- Masse moléculaire:726.68
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
WMK-2 (37b) showed potent and broad-spectrum antiproliferative activity across numerous cancer cell lines. It potently inhibited MDA-MB-231, HCT116, T47D, HepG2, HeLa, HEK293, MCF7, PLC, U2OS, and Huh7 cells with IC50 values of 0.38, 0.6, 0.62, 0.7, 1.6, 1.6, 2.4, 2.7, 3.4, and 3.8 μM, respectively. Meanwhile, WMK-2 displayed favorable selectivity toward normal cells, with IC50 values of 4.6 μM (NIH3T3), 5.2 μM (bEnd.3), and 9.5 μM (MDCK), corresponding to a selectivity index greater than 7.6[1].
WMK-2 (48 h) inhibits HeyA8 adherent ovarian cancer cell viability with an IC50 of 1.4 μM and HeyA8 ovarian cancer stem cell spheroid viability with an IC50 of 1.1 μM after 48 h of incubation, showing a selectivity index greater than 11 relative to non-cancerous NIH3T3 cells[1].
WMK-2 induces ferroptosis in both HeyA8 ovarian cancer stem cells and MDA-MB-231 breast cancer cells[1].
WMK-2 (1 μM; 6 h) induces significant lipid ROS generation in MDA-MB-231 breast cancer cells, confirming ferroptosis-associated lipid peroxidation[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Nude mice (female, HEYA8 CSC xenograft model)[1]
-
Dosage:5 mg/kg; 10 mg/kg
-
Administration:i.p.
-
Result:Effectively inhibited ovarian tumor growth compared with vehicle control.
Showed well-tolerated safety profile with no abnormal behavior or weight loss noted during treatment period.
Chemical Information
-
CAS No. 2814563-63-6
-
Masse moléculaire 726.68
-
Formule C38H49BrNO6P
-
SMILES
CC(C)(C)C1CCC2(OOC3(CCC(OC(NCCC[P+](C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6)=O)CC3)OO2)CC1.[Br-]
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)